Tonti v. Naficy CA4/3

CourtCalifornia Court of Appeal
DecidedJanuary 23, 2023
DocketG060814
StatusUnpublished

This text of Tonti v. Naficy CA4/3 (Tonti v. Naficy CA4/3) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Tonti v. Naficy CA4/3, (Cal. Ct. App. 2023).

Opinion

Filed 1/23/23 Tonti v. Naficy CA4/3

NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FOURTH APPELLATE DISTRICT

DIVISION THREE

ALISON TONTI,

Plaintiff and Appellant, G060814

v. (Super. Ct. No. 30-2019-01116243)

K. MITCHELL NAFICY, OPI NION

Defendant and Respondent.

Appeal from a judgment and orders of the Superior Court of Orange County, Theodore R. Howard, Judge. Affirmed in part, reversed in part, and remanded. Medvei Law Group and Sebastian M. Medvei for Plaintiff and Appellant. Peterson Bradford Burkwitz, Thomas Bradford and Gil Burkwitz for Defendant and Respondent. * * * INTRODUCTION This appeal arises from a judgment in favor of defendant Dr. K. Mitchell Naficy following orders sustaining demurrers and an order granting summary judgment. In December 2018, plaintiff Alison Tonti received substance abuse treatment at a residential detoxification facility operated by codefendant Capo By The Sea, Inc. (Capo). According to Tonti, she was not examined by Naficy prior to receiving a drug prescription given to ease her anticipated withdrawal symptoms. Tonti alleges that days later, she lost consciousness as a result of the drug and suffered a substance abuse relapse. Shortly thereafter, she withdrew from Capo and filed the underlying lawsuit against Naficy, Capo, and a Capo staff member, asserting three claims against Naficy. Relevant to this appeal, Naficy filed successful demurrers against Tonti’s claims for violation of the unfair competition law (UCL) (Bus. & Prof. Code, § 17200 et 1 seq.) and willful misconduct. Naficy then filed a motion for summary judgment (MSJ) against Tonti’s remaining medical malpractice claim. In support, Naficy submitted Tonti’s medical records and a declaration of a proposed expert witness who presented opinions based on the records. In her opposition to the MSJ, Tonti asserted evidentiary objections to the records, arguing they were hearsay and not properly authenticated. The trial court overruled the objections and granted the MSJ. Tonti asserts the trial court erroneously sustained Naficy’s demurrers and incorrectly overruled her objections to the admissibility of her medical records. We conclude Tonti has shown one of the demurrers was erroneously sustained and agree her medical records lacked proper authentication to support Naficy’s MSJ. We affirm the court’s order sustaining Naficy’s demurrer to Tonti’s original complaint willful misconduct claim, reverse the court’s order sustaining Naficy’s demurrer to Tonti’s amended complaint UCL claim, reverse the grant of summary judgment, and remand this matter for further proceedings.

1 All further undesignated statutory references are to the Business & Professions Code.

2 2 FACTUAL BACKGROUND In December 2018, Tonti admitted herself to Capo to receive residential substance detoxification services for a fee of $10,000. A Capo staff member that Tonti has designated in her complaint as “Jeff Doe” drove Tonti there. Relevant to her claims against Naficy, Tonti asserts that upon arriving at Capo, she “did not meet with any doctors, and did not have any kind of examination by a licensed health care professional.” Tonti alleges that, notwithstanding the lack of an examination, she received prescriptions for medication treatments known as “taper[s],” which she explains are “designed to ease a [substance abuse disorder] patient through detoxification and into abstinence . . . by using medications to alleviate and control the severe pain from withdrawals associated with detoxification and abstinence.” Tonti asserts that after she complained about her first taper treatment, Doe called Naficy who, without examining Tonti, prescribed for the next treatment “a 30-day protocol of [b]enzodiazepine.” Because she had no direct line of communication to Naficy, Tonti told Doe she “did not feel comfortable taking [the b]enzodiazopene as part of [her treatment] because her past experience with it had led to unfortunate side effects.” Notwithstanding, Doe “required [Tonti] to continue with the [b]enzodiaz[e]p[i]ne protocol,” according to her allegations. After beginning the benzodiazepine taper, Tonti asserts she had an episode where she “blacked out” and during that time obtained heroin, relapsing into substance abuse. Tonti alleges she was transferred to a lower security location by Capo and unsuccessfully demanded to be returned to a residential facility. “[F]earing another relapse,” she “cease[d] enrollment with” Capo and unsuccessfully demanded a refund.

2 The factual allegations discussed are limited to the issues material to our disposition of this appeal.

3 Tonti alleges that if Naficy had “conducted a non-negligent work up” that included “an inquiry into [Tonti]’s particular substance sensitivities . . . Naficy would have discovered that [Tonti] ha[d a] very low tolerance for [the Benzodiazepine] as it is outside the scope of the typical substances related to” Tonti’s substance abuse disorder. She alleges the defendants “engaged in a conspiracy, common enterprise, and common course of conduct, the purpose of which is and was to engage in the violations of law alleged.” She seeks restitution of the $10,000 she paid to Capo, compensatory and punitive damages, and declarative as well as injunctive relief.

PROCEDURAL HISTORY In Tonti’s original and amended complaint, she alleges six causes of action against various defendants: (1) professional negligence; (2) negligence; (3) “intentional conduct”; (4) breach of contract; (5) intentional misrepresentation; and (6) violation of the UCL. Only three of the claims were alleged against Naficy: professional negligence, “intentional conduct,” and violation of the UCL. Tonti’s claims for “intentional conduct” and violation of the UCL were eliminated at the pleadings stage of litigation. Specifically, the trial court sustained Naficy’s first demurrer against the two claims with leave to amend. In her amended complaint, Tonti only reasserted professional negligence and violation of the UCL against Naficy, adding some factual specificity for the latter. Naficy filed a second demurrer, against the UCL claim, that the trial court sustained. Although leave to amend was again granted, Tonti failed to do so and proceeded against Naficy on the professional negligence claim only. Five months later, in May 2021, Naficy filed an MSJ on Tonti’s professional negligence claim. In support, he filed a declaration by proposed expert witness Dr. Darryl J. Ballin, who specialized in “addiction medicine.” Ballin presented opinions supporting Naficy’s positions on the applicable standard of care, causation, and

4 damages claimed, including his opinion that the taper prescription Tonti relies on did not cause the “‘black out’” episode she claims to have suffered. The opinions were based on Naficy’s presentation of Tonti’s medical records purportedly documenting her treatments received through Naficy’s practice and Capo which had been filed in the trial court. Naficy presented defense discovery verifications as the foundations for the records. Tonti’s opposition to the MSJ included written evidentiary objections to Ballin’s declaration as well as hearsay and foundation objections to the presented medical records. The trial court overruled Tonti’s objections, citing Evidence Code section 720 and Shugart v. Regents of University of California (2011) 199 Cal.App.4th 499 (Shugart). The court granted Naficy’s MSJ and entered judgment. Tonti timely appealed.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Zhang v. Superior Court
304 P.3d 163 (California Supreme Court, 2013)
Cobbs v. Grant
502 P.2d 1 (California Supreme Court, 1972)
Berkley v. Dowds
61 Cal. Rptr. 3d 304 (California Court of Appeal, 2007)
City of Vista v. Robert Thomas Securities, Inc.
101 Cal. Rptr. 2d 237 (California Court of Appeal, 2000)
Steinsmith v. Medical Board of California
102 Cal. Rptr. 2d 115 (California Court of Appeal, 2000)
Whyte v. Schlage Lock Company
125 Cal. Rptr. 2d 277 (California Court of Appeal, 2002)
Perlin v. Fountain View Management, Inc.
163 Cal. App. 4th 657 (California Court of Appeal, 2008)
Hamburg v. Wal-Mart Stores, Inc.
10 Cal. Rptr. 3d 568 (California Court of Appeal, 2004)
Podolsky v. First Healthcare Corp.
50 Cal. App. 4th 632 (California Court of Appeal, 1996)
Garibay v. Hemmat
74 Cal. Rptr. 3d 715 (California Court of Appeal, 2008)
Aguilar v. Atlantic Richfield Co.
24 P.3d 493 (California Supreme Court, 2001)
Munson v. Del Taco, Inc.
208 P.3d 623 (California Supreme Court, 2009)
Wiener v. Southcoast Childcare Centers, Inc.
88 P.3d 517 (California Supreme Court, 2004)
Reid v. Google, Inc.
235 P.3d 988 (California Supreme Court, 2010)
Evans v. City of Berkeley
129 P.3d 394 (California Supreme Court, 2006)
People v. Cole
135 P.3d 669 (California Supreme Court, 2006)
Ram v. OneWest Bank, FSB
234 Cal. App. 4th 1 (California Court of Appeal, 2015)
Nolte v. Cedars Sinai Medical Center
236 Cal. App. 4th 1401 (California Court of Appeal, 2015)
Crawley v. Alameda County Waste Management Authority
243 Cal. App. 4th 396 (California Court of Appeal, 2015)
Winn v. Pioneer Medical Group, Inc.
370 P.3d 1011 (California Supreme Court, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Tonti v. Naficy CA4/3, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tonti-v-naficy-ca43-calctapp-2023.